Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
| Descriptor ID |
D003131
|
| MeSH Number(s) |
E02.186
|
| Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 14 | 14 |
| 1997 | 0 | 12 | 12 |
| 1998 | 0 | 15 | 15 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 15 | 15 |
| 2001 | 2 | 18 | 20 |
| 2002 | 1 | 14 | 15 |
| 2003 | 0 | 25 | 25 |
| 2004 | 0 | 22 | 22 |
| 2005 | 0 | 32 | 32 |
| 2006 | 0 | 23 | 23 |
| 2007 | 1 | 32 | 33 |
| 2008 | 0 | 42 | 42 |
| 2009 | 0 | 30 | 30 |
| 2010 | 0 | 39 | 39 |
| 2011 | 0 | 34 | 34 |
| 2012 | 0 | 25 | 25 |
| 2013 | 2 | 38 | 40 |
| 2014 | 0 | 32 | 32 |
| 2015 | 1 | 35 | 36 |
| 2016 | 0 | 53 | 53 |
| 2017 | 3 | 52 | 55 |
| 2018 | 3 | 45 | 48 |
| 2019 | 2 | 52 | 54 |
| 2020 | 0 | 37 | 37 |
| 2021 | 2 | 32 | 34 |
| 2022 | 0 | 10 | 10 |
| 2023 | 0 | 10 | 10 |
| 2024 | 0 | 21 | 21 |
| 2025 | 0 | 8 | 8 |
| 2026 | 0 | 8 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
A Primer for Pediatric Plastic Surgeons on Pediatric Head and Neck Malignancies: Part III-Common Management Strategies for Pediatric Head and Neck Tumors. Ann Plast Surg. 2026 Jun 01; 96(6):534-540.
-
A Primer for Pediatric Plastic Surgeons on Pediatric Head and Neck Malignancies: Part IV-Common Disease-Specific Management Strategies for Pediatric Head and Neck Tumors. Ann Plast Surg. 2026 Jun 01; 96(6):541-551.
-
Malignant peripheral nerve sheath tumors: a report from Children's Oncology Group study ARST0332. J Natl Cancer Inst. 2026 May 01; 118(5):829-838.
-
Geroprotective effects of diet and exercise plus metformin in frail older veterans with obesity: The DEMFOS randomized trial protocol. Contemp Clin Trials. 2026 Jun; 165:108321.
-
Intermediate Risk Rhabdomyosarcoma in Very Young Children (Less Than or Equal to 24 Months) Treated on the Prior Children's Oncology Group Protocol ARST1431. Pediatr Blood Cancer. 2026 Jun; 73(6):e70293.
-
Alveolar Soft Part Sarcoma in Pediatric and Young Adult Patients: A Report From the Children's Oncology Group Study ARST0332. Pediatr Blood Cancer. 2026 May; 73(5):e70228.
-
Established and Emerging Therapies for High-Risk Neuroblastoma. Paediatr Drugs. 2026 Mar; 28(2):159-175.
-
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis. JCO Glob Oncol. 2026 Jan; 12:e2400435.
-
Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial. Ann Surg Oncol. 2026 Apr; 33(4):2899-2907.
-
The Benefits of Exercise Training in Combination With Weight Loss Therapies. Diabetes. 2025 Dec 01; 74(12):2199-2206.